参考文献/References:
[1] Fischer LM, Schlienger RG, Matter C, et al. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction[J]. Am J Cardiol,2004,93(2):198-200.
[2] Svenungsson E, Jensen-Urstad K, Heimburger M, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus[J]. Circulation,2001,104(16):1887-1893.
[3] Urowitz MB, Gladman D, Ibañez D, et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus[J]. Arthritis Care Res(Hoboken),2010,62(6):881-887.
[4] Bruce IN, Urowitz MB, Gladman DD, et al. Natural history of hypercholesterolemia in systemic lupus erythematosus[J]. J Rheumatol,1999,26(11):2137-2143.
[5] Elsy AGV, Israel LG, Luis FFS, et al. Prognostic value of metabolic syndrome for the development of cardiovascular disease in a cohort of premenopausal women with systemic lupus erythematosus[J].Medicina Clínica,2015,144(7):289-296.
[6] AI Husain A, Bruce IN.Risk factors for coronary heart disease in connective tissue disease[J].Ther Adv Musculoskel Dis,2010,2(3):145-153.
[7] Yang L, Tao J, Tang X, et al. Prevalence and correlation of conventional and lupus specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients[J]. J Eur Acad Dermatol, 2012,26(7):95-101.
[8] AI Gadban MM, Alwan MM,Smith KJ,et al. Accelerated vascular disease in systemic lupus erythematosus: role of macrophage[J].Clin Immunol,2015,157(2):133-144.
[9] de Matos Soeiro A, de Almeida Soeiro MC, de Oliveira MT Jr,et al. Clinical characteristics and in-hospital outcome of patients with acute coronary syndromes and systemic lupus erythematosus[J]. Rev Port Cardiol, 2014,33(11):685-690.
[10] Hanan E,Manal AE,Timour M,et al.Thyroid dysfunction in systemic lupus erythematosus and rheumatoid arthritis: its impact as a cardiovascular risk factor[J]. Egyptian Rheumatol,2014,36(3):71-78.
[11] Nailú AS, Priscila ASC,Simone A.Risk factors in cardiovascular disease in systemic lupus erythematosus[J]. Curr Cardiol Rev,2013,9(3):15-19.
[12] Faden G, Viapiana O, Fischetti F, et al.Cardiovascular risk stratification and management of patients with rheumatoid arthritis in clinical practice: The EPIDAURO registry[J]. Int J Cardiol,2014,172(2):534-536.
[13] Pieringer H, Brummaier T, Schmid M,et al. Rheumatoid arthritis is an independent risk factor for an increased augmentation index regardless of the coexistence of traditional cardiovascular risk factors[J].Rheumatoid Arthritis,2012,42(1):17-22.
[14] Farragher TM, Goodson NJ, Naseem H, et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease,in patients with rheumatoid arthritis and inflammatory polyarthritis[J]. Arthritis Rheum,2008,58(2):359-369.
[15] Choi HK, Hernán MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study[J]. Lancet,2002,359(9313):1173-1177.
[16] Cheung YF, Wong SJ, Ho MH, et al. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease[J]. Arch Dis Child,2007,92(1):43-47.
[17] Mok MY, Chiu SS,Lo Y, et al.Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis[J]. Scand J Rheumatol,2009,38(5):381-385.
[18] Tisseverasinghe A,Bernatsky S,Pineau CA. Arterial events in persons with dermatomyositis and polymyositis[J]. J Rheumatol,2009,36(9):1943-1946.
相似文献/References:
[1]徐学萍 汪汉 蔡琳.结缔组织病相关心脏瓣膜病[J].心血管病学进展,2019,(9):1267.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.021]
XU Xueping,WANG Han,CAI Lin.Connective Tissue Disease-associated Valvular Heart Disease[J].Advances in Cardiovascular Diseases,2019,(5):1267.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.021]
[2]杨晓倩 张艺文 秦 莉 汪 汉.基于CiteSpace的结缔组织病相关肺动脉高压的文献分析[J].心血管病学进展,2021,(12):1129.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.018]
YANG Xiaoqian,ZHANG Yiwen,QIN Li,et al.Literature Analysis of Connective Tissue Disease-Related Pulmonary ArteriaHypertension Based on CiteSpace[J].Advances in Cardiovascular Diseases,2021,(5):1129.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.018]
[3]杨子玄?刘圣?亢玉?张庆.新指标评估结缔组织病患者动脉僵硬度及其对左室舒张功能的影响[J].心血管病学进展,2022,(5):475.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.021]
YANG Zixuan,LIU Sheng,KANG Yu,et al.Arterial Stiffness Assessed by New Indices in Patients with Connective Tissue Disease and Their Association with Left Ventricular Diastolic Function[J].Advances in Cardiovascular Diseases,2022,(5):475.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.021]
[4]唐建辉 陈锋 汪汉.血清尿酸与结缔组织病[J].心血管病学进展,2022,(8):743.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.019]
TANG Jianhui,CHEN Feng,WANG Han?/html>.Serum Uric Acid and Connective Tissue Diseases[J].Advances in Cardiovascular Diseases,2022,(5):743.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.019]